| Literature DB >> 12525737 |
L B Morgenstern1, C M Viscoli, W N Kernan, L M Brass, J P Broderick, E Feldmann, J L Wilterdink, T Brott, R I Horwitz.
Abstract
This case-control study examined the association between Ephedra use and risk for hemorrhagic stroke. For use of Ephedra at any dose during the 3 days before the stroke, the adjusted OR was 1.00 (95% CI 0.32 to 3.11). For daily doses of < or =32 mg/day, the OR was 0.13 (95% CI 0.01 to 1.54), and for >32 mg/day, the OR was 3.59 (95% CI 0.70 to 18.35). Ephedra is not associated with increased risk for hemorrhagic stroke, except possibly at higher doses.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12525737 DOI： 10.1212/01.wnl.0000042092.20411.5b
Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910